Golimumab

Review
In: Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006.
.

Excerpt

Limited information on golimumab indicates that it is almost undetectable in breastmilk. It is also likely to be partially destroyed in the infant's gastrointestinal tract and absorption by the infant is probably minimal.[1] Until more data become available, golimumab should be used with caution during breastfeeding, especially while nursing a newborn or preterm infant. Most experts and guidelines consider golimumab to be probably acceptable to use during nursing.[2-9] Waiting for at least 2 weeks postpartum to resume therapy may minimize transfer to the infant.[10]

Publication types

  • Review